 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO  Get Free Report) CFO Cecilia Jones sold 2,179 shares of the companys stock in a transaction that occurred on Thursday, September 28th. The...

Insider Selling: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) CFO Sells 2,179 Shares of Stock

This is a signal that AGIO's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Agios Pharmaceuticals (AGIO, $24.54) RSI Indicator left the oversold zone on September 27, 2023

This price move could indicate a change in the trend, and may be a sell signal for investors...

Agios Pharmaceuticals (AGIO, $26.56) price exceeded its 50-day Moving Average on September 06, 2023

This indicator may be signaling that AGIO's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Agios Pharmaceuticals (AGIO, $26.56) entered Downtrend as Momentum indicator drops below 0 level on Sep 06, 2023

Investors eyeing a purchase of Agios Pharmaceuticals Inc (AGIO) shares, but cautious about paying the going market price of 26.45/share, might benefit from considering selling puts among the...

Commit To Buy Agios Pharmaceuticals At $22.50, Earn 10.4% Annualized Using Options

Credit Suisse AG boosted its holdings in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO  Free Report) by 6.1% during the 1st quarter, according to the company in its most recent...

Credit Suisse AG Has $2.35 Million Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Russell Investments Group Ltd. boosted its stake in shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO Free Report) by 31.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 49,840 shares of the biopharmaceutical ...

Russell Investments Group Ltd. Has $1.15 Million Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field of cellular metabolism pioneering therapies for rare diseases, today announced that the company is scheduled to present at the Morgan Stanley 21st Annual Global Healthcare Conference...

Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023

Skandinaviska Enskilda Banken AB publ lessened its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO Free Report) by 4.6% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 29,360 shares of the biopharmaceutical companys stock after selling 1,403 ...

Skandinaviska Enskilda Banken AB publ Sells 1,403 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Agios Pharmaceuticals (AGIO, $26.59) price exceeded its 50-day Moving Average on August 24, 2023

Agios Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.

Watchers	2,480
52-Wk Low	$21.07
52-Wk High	$31.87

Market Cap	$1.35B
Volume (M)	327,040.00
52-Wk High	$31.87
52-Wk Low	$21.07

AGIO Agios Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals